Bank of Montreal
SCNI

Bank of Montreal’s Scinai Immunotherapeutics SCNI Stock Holding History

Bank of Montreal’s Portfolio SCNI Stock Details SCNI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$22.9K – 3778
2025
Q2 		$22.9K Buy
+10,000
New +$25.2K ﹤0.01% 3264
2017
Q1 		– Sell
-120
Closed -$44K – 4164
2016
Q4 		$44K Sell
120
-30
-20% -$10.9K ﹤0.01% 3156
2016
Q3 		$55K Hold
150
– – ﹤0.01% 3021
2016
Q2 		$53K Hold
150
– – ﹤0.01% 3040
2016
Q1 		$56K Hold
150
– – ﹤0.01% 3010
2015
Q4 		$59K Hold
150
– – ﹤0.01% 2972
2015
Q3 		$55K Buy
+150
New +$61.3K ﹤0.01% 2882

Other funds holding SCNI

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of Montreal's SCNI Position: Q3 2025 in Review

Bank of Montreal sold out of Scinai Immunotherapeutics (SCNI) in Q3 2025, closing a stake of 10,000 shares — an estimated $22.9K sold.

Bank of Montreal first reported a position in SCNI in Q3 2015 and held it in 7 quarters. The position peaked at $59K in Q4 2015. 6 funds tracked by Wall St. Rank hold SCNI as of Q3 2025.

  • Bank of Montreal reported no remaining Scinai Immunotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 10,000 Scinai Immunotherapeutics shares in Q3 2025, an estimated $22.9K.
  • Bank of Montreal first reported a position in Scinai Immunotherapeutics in Q3 2015 and held it in 7 quarters.
  • Bank of Montreal's Scinai Immunotherapeutics position peaked at $59K in Q4 2015.
  • 6 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.